Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome

Current Rheumatology Reports

Volumn 12, Issue 1, 2010, Pages 70-76

  Cervera, Ricard ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Catastrophic antiphospholipid syndrome; Lupus anticoagulant

Indexed keywords

ANCROD; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEFIBROTIDE; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PROSTACYCLIN; RITUXIMAB; STEROID; WARFARIN;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTIFICIAL VENTILATION; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOPSY; BLOOD VESSEL OCCLUSION; CLINICAL FEATURE; DISEASE REGISTRY; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPOTENSION; LABORATORY TEST; MICROANGIOPATHY; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PLASMAPHERESIS; PROGNOSIS; RECOMMENDED DRUG DOSE; RECURRENCE RISK; RESPIRATORY FAILURE; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE ORGAN FAILURE; PLASMA EXCHANGE;

EID: 77249176999     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0073-6     Document Type: Review

References (37)

1. RA Asherson 1992 The catastrophic antiphospholipid antibody syndrome J Rheumatol 19 508 512 1:STN:280:DyaK383nslGltg%3D%3D 1593568
2. JC Piette R Cervera R Levy, et al. 2003 The catastrophic antiphospholipid syndrome-Asherson's syndrome Ann Med Intern 154 95 96
3. RA Asherson R Cervera JC Piette, et al. 1998 Catastrophic antibody syndrome. Clinical and laboratory features of 50 patients Medicine (Baltimore) 77 195 207 10.1097/00005792-199805000-00005 1:STN:280:DyaK1czhsleisQ%3D%3D (Pubitemid 28290020)
4. RA Asherson R Cervera JC Piette, et al. 2001 Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients Medicine (Baltimore) 80 355 376 10.1097/00005792-200111000-00002 1:STN:280:DC%2BD3MnnvFWmtg%3D%3D (Pubitemid 33070843)
5. S Bucciarelli G Espinosa R Cervera, et al. 2006 Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients Arthritis Rheum 54 2568 2576 10.1002/art.22018 16868979 (Pubitemid 44205018)
6. R Cervera JC Piette J Font, et al. 2002 Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients Arthritis Rheum 46 1019 1027 10.1002/art.10187 11953980 (Pubitemid 34303815)
7. RA Asherson R Cervera P de Groot, et al. 2003 Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines Lupus 12 530 534 10.1191/0961203303lu394oa 1:STN:280:DC%2BD3szlvFCnug%3D%3D 12892393 (Pubitemid 36890145)
8. R Cervera J Font JA Gómez-Puerta, et al. 2005 Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome Ann Rheum Dis 64 1205 1209 10.1136/ard.2004.025759 1:CAS:528: DC%2BD2MXpslGms70%3D 15708888 (Pubitemid 41113358)
9. R Cervera S Bucciarelli MA Plasín, et al. 2009 Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry" J Autoimmun 32 240 245 10.1016/j.jaut.2009.02.008 1:CAS:528:DC%2BD1MXls12qsLY%3D 19324520 This article discusses the largest series (n = 280) of patients with catastrophic APS
10. G Espinosa R Cervera RA Asherson 2007 Catastrophic antiphospholipid syndrome and sepsis: a common link? J Rheumatol 34 923 926 1:CAS:528: DC%2BD2sXmtV2rt7s%3D 17477476 (Pubitemid 46774833)
11. R Cervera J Font A Tincani MC Boffa 2006 V Meeting of the European Forum on Antiphospholipid Antibodies Autoimm Rev 5 499 507 10.1016/j.autrev.2006.01. 001 1:CAS:528:DC%2BD28XhtVyns7bN (Pubitemid 44233400)
12. RA Asherson G Espinosa S Menahem, et al. 2008 Relapsing catastrophic antiphospholipid syndrome: report of three cases Semin Arthritis Rheum 37 366 372 10.1016/j.semarthrit.2007.08.001 17977582 (Pubitemid 351734518)
13. JA Gomez-Puerta R Cervera G Espinosa, et al. 2007 Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases Ann Rheum Dis 66 740 746 10.1136/ard.2006.061671 17223653 (Pubitemid 46846692)
14. W Miesbach RA Asherson R Cervera, et al. 2007 The role of malignancies in patients with catastrophic antiphospholipid (Asherson's) syndrome Clin Rheumatol 26 2109 2114 10.1007/s10067-007-0634-x 1:STN:280: DC%2BD2snmsFaitg%3D%3D 17522949 (Pubitemid 350120350)
15. R Cervera G Espinosa A Cordero, et al. 2007 Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS Semin Arthritis Rheum 36 287 296 10.1016/j.semarthrit.2006.09.003 1:CAS:528:DC%2BD2sXjvFOntb4%3D 17207521 (Pubitemid 46517629)
16. HM Belmont SB Abramson JT Lie 1996 Pathology and pathogenesis of vascular injury in systemic lupus erythematosus Arthritis Rheum 39 9 22 10.1002/art.1780390103 1:STN:280:DyaK287jtlamtQ%3D%3D 8546744 (Pubitemid 26036373)
17. S Bucciarelli G Espinosa RA Asherson, et al. 2006 The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients Ann Rheum Dis 65 81 86 10.1136/ard.2005.037671 1:STN:280:DC%2BD2MnmtFCgsQ%3D%3D 15919677 (Pubitemid 41815644)
18. RA Asherson G Espinosa R Cervera, et al. 2005 Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients Ann Rheum Dis 64 943 946 10.1136/ard.2004.026377 1:STN:280:DC%2BD2M3lsFCqsQ%3D%3D 15897312 (Pubitemid 40733924)
19. G Espinosa S Bucciarelli R Cervera, et al. 2004 Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies Ann Rheum Dis 63 730 736 10.1136/ard.2003.007245 1:STN:280:DC%2BD2c3ktFKgug%3D%3D 15140782 (Pubitemid 38658405)
20. RA Asherson R Cervera J Font 1992 Multiorgan thrombotic disorders in systemic lupus erythematosus: a common link? Lupus 1 199 203 10.1177/096120339200100402 1:STN:280:DyaK3s3ltV2gtA%3D%3D 1301983
21. RA Asherson SS Pierangeli R Cervera 2007 Is there a microangiopathic antiphospholipid syndrome? Ann Rheum Dis 66 429 432 10.1136/ard.2006.067033 1:CAS:528:DC%2BD2sXkvFeksrY%3D 17360782 (Pubitemid 46580459)
22. RA Asherson SS Pierangeli R Cervera 2007 Microangiopathic antiphospholipid-associated syndromes revisited: new concepts relating to antiphospholipid antibodies and syndromes J Rheumatol 34 1793 1795 17787048
23. R Asherson R Cervera 2008 Microvascular and microangiopathic antiphospholipid-associated syndromes (MAPS): semantic or antisemantic? Autoimm Rev 7 164 167 10.1016/j.autrev.2007.11.009 1:CAS:528:DC%2BD1cXis1Wgu7c%3D
24. G Girardi P Redecha JE Salmon 2004 Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation Nat Med 10 1222 1226 10.1038/nm1121 1:CAS:528:DC%2BD2cXptVOgsbc%3D 15489858 (Pubitemid 39540439)
25. JW Christman LH Lancaster TS Blackwell 1998 Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy Intensive Care Med 24 1131 1138 10.1007/s001340050735 1:STN:280:DyaK1M%2Fpt1yjsw%3D%3D 9876974 (Pubitemid 28542926)
26. I Uthman A Shamseddine A Taher 2005 The role of therapeutic plasma exchange in catastrophic antiphospholipid syndrome Transfus Apher Sci 33 11 17 10.1016/j.transci.2004.10.025 15951243 (Pubitemid 40982143)
27. H Orbach U Katz Y Sherer Y Shoenfeld 2005 Intravenous immunoglobulin: adverse effects and safe administration Clin Rev Allergy Immunol 29 173 184 10.1385/CRIAI:29:3:173 1:CAS:528:DC%2BD28XosVOqtg%3D%3D 16391392 (Pubitemid 43041668)
28. UD Bayraktar D Erkan S Bucciarelli, et al. 2007 The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus J Rheumatol 34 346 352 17304658
29. R Tenedious D Erkan MD Lockshin 2005 Rituximab in the primary antiphospholipid syndrome [abstract] Arthritis Rheum 52 4078
30. JG Erdozain G Ruiz-Irastorza MV Egurbide, et al. 2004 Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome [abstract] Haematologica 89 ECR34 1:STN:280:DC%2BD2cvmslamsQ%3D%3D 15377486
31. E Rubenstein DG Arkfeld S Metyas, et al. 2006 Rituximab treatment for resistant antiphospholipid syndrome J Rheumatol 33 355 357 16465669
32. AK Dosekun VE Pollak P Glas-Greenwalt, et al. 1984 Ancrod in systemic lupus erythematosus with thrombosis: clinical and fibrinolysis effects Arch Intern Med 144 37 42 10.1001/archinte.144.1.37 1:STN:280:DyaL2c7gtlCmtw%3D%3D 6229228 (Pubitemid 14217959)
33. LH Yang DA Hoppensteadt O Iqbal J Fareed 1996 Defibrotide mediated inhibition of serotonin, endothelin-I, thromboxane, and serum induced contraction of canine femoral and pulmonary arterial rings Thromb Res 84 167 177 10.1016/0049-3848(96)00173-9 1:CAS:528:DyaK28Xntlegu7k%3D 8914216 (Pubitemid 26375238)
34. S Vero RA Asherson D Erkan 2006 Critical care review: catastrophic antiphospholipid syndrome J Intensive Care Med 21 144 159 10.1177/ 0885066606287041
35. S Bucciarelli D Erkan G Espinosa R Cervera 2009 Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse Clinic Rev Allerg Immunol 38 80 84 10.1007/s12016-008-8107-9
36. D Erkan RA Asherson G Espinosa, et al. 2003 The long-term outcome of catastrophic antiphospholipid syndrome survivors Ann Rheum Dis 62 530 533 10.1136/ard.62.6.530 1:STN:280:DC%2BD3s3ltVKgsQ%3D%3D 12759289 (Pubitemid 36606285)
37. S Bucciarelli G Espinosa A Bové, et al. 2007 Relapsing catastrophic antiphospholipid syndrome [abstract] Ann Rheum Dis 66 304